Delivery Order SPE2DB22D3501-SPE2DB25FXD57
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $16,947.60 on August 27, 2025, for the supply of Spravato 84 mg dose pack unit dose systems. This firm fixed-price delivery order, with a completion date of August 28, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support Medical. The contract was...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,829.09 to AmerisourceBergen Drug Corp for the supply of SPRAVATO 84 mg dose pack UDS (unit dose packages). This firm fixed price delivery order, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. SPRAVATO (esketamine) is a prescription nasal spray used in treating...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $42,120.60, is for the delivery of SPRAVATO 84 MG DOSE PACK medical supplies. The contract is a firm-fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and the place of performance is...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SPRAVATO 84 MG DOSE PACK UDS, a pharmaceutical product. The contract has a firm fixed price of $8,466.28 and a completion date of April 30, 2025. This contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order awarded by the Department of Defense's Medical Supply Chain organization to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Spravato 84 mg dose packs. The $22,963.32 firm fixed-price contract has a completion date of May 15, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has extensive experience fulfilling government contracts for a variety of prescription medications, medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of SPRAVATO 84 MG DOSE PACK UDS. The firm fixed price contract has a potential value of $14,978.16 and a completion date of December 26, 2023. Amerisourcebergen Drug Corp is a prime contractor that provides pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. The contract does not...
- Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide SPRAVATO 84 MG DOSE PACK UDS, a pharmaceutical product, for a potential value of $8,484.59. The contract has a completion date of March 6, 2024. This delivery order is likely part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA to supply a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of SPRAVATO 84 MG DOSE PACK UDS, a medical product, with a ceiling value of $8,812.72. The contract is a firm-fixed price delivery order with a completion date of June 9, 2025. This award is not associated with a set-aside program, indicating open competition. AmerisourceBergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $15,328.09 firm fixed-price delivery order is for the supply of SPRAVATO 84 MG DOSE PACK UDS, a pharmaceutical product, with a period of performance through February 22, 2024. The award was not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $22,963.32, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of SPRAVATO 84 MG DOSE PACK UDS, a pharmaceutical product, with a performance period through August 1, 2024. This award is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which enables the company to...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXD57Delivery Order
The Defense Logistics Agency awarded a $8,485.09 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Spravato 84 mg dose pack unit dose systems (UDS). The contract, which is not set-aside and competitively awarded, has an ultimate completion date of September 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in Conshohocken, PA 19428. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive pharmaceutical support vehicle enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs globally. Spravato, an FDA-approved nasal spray medication for depression treatment, represents a specialized pharmaceutical commodity within the Defense Health Agency's medical supply chain, reflecting the company's role in providing brand-name specialty medications to federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 9/3/25 |